Download material
Create a supply chain adaptable to disruption and able to contribute to strong environmental and social performance.
Environmental, Social, and Governance
- Global Public Health
- Sustainability
- Inclusion and Diversity
Working to strengthen healthcare systems across the world by developing and deploying market-appropriate solutions
BD Global Public Health works to align activities, priorities and development efforts around the world's leading public health needs. We drive access to existing BD solutions and develop and deploy innovations to address priority health needs in areas aligned with the Sustainable Development Goals (SDGs).
To achieve positive societal outcomes, we utilize various methods including innovative commercial business models, public-private partnerships, market development activities and global advocacy. Established in 2004, BD Global Public Health champions private sector engagement with international agencies, nongovernmental organizations and governments on global, regional and local levels with a goal to enhance access to health for all people.
Collaborating to help curb the spread of resistant infections
Antimicrobials—drugs that kill infectious bacteria, viruses, parasites and fungi—are a mainstay of modern medicine. However, limited development of new medicines and decades of outmoded use have driven increases in the number of microbes resistant to these lifesaving drugs.
Our ongoing efforts align with best practices that control antimicrobial resistance (AMR) and include a broad portfolio of AMR solutions that support the following areas:
- Infection prevention and control. BD capabilities help reduce the incidence of healthcare-associated infections (HAIs) and the spread of antimicrobial-resistant organisms.
- Diagnostic testing. BD capabilities enable clinicians to accurately identify infections, appropriately tailor treatment and avoid unnecessary antibiotic use.
- Surveillance and reporting. BD efforts help identify patients at greatest risk of acquiring resistant infections, monitor population-based trends and provide early warning for outbreaks.
Collectively, these capabilities enhance our customers' ability to contain AMR and achieve effective antimicrobial stewardship. Our recently formed, cross-company AMR team, working with the Office of the UN Secretary-General's Special Envoy for Health in Agenda 2030 and for Malaria, the UK Mission to the United Nations, the Joint United Nations Programme on HIV/AIDS (UNAIDS), United Nations Unies and the Review on Antimicrobial Resistance, has helped organize forums at events such as the United Nations General Assembly meeting in New York and the World Economic Forum Annual Meeting in Davos, Switzerland. Featured speakers have included Prof. Dame Sally Claire Davies, Chief Medical Officer for England; Lord Jim O'Neill, Chair of the AMR Review and U.K. Commercial Secretary to the Treasury; and Dr. Thomas Frieden, Director of the U.S. Centers for Disease Control and Prevention. At the UN General Assembly meeting, Renuka Gadde from BD Global Public Health stated that "AMR has no single solution, and the challenges cannot be solved without multiple players working collectively on a common AMR agenda."
Tackling global antimicrobial resistance on 10 fronts
Global stakeholders join forces in the fight against antimicrobial resistance
Addressing healthcare challenges through cross-sector collaborations with key local, regional and global organizations
Channeling products, resources and collaborative efforts to address fundamental health issues
A holistic approach is needed to combat complex infectious diseases such as TB and HIV & AIDS.
BD Global Public Health applies the company's technologies, resources and expertise across the continuum of care required to address these problems—from preventing disease transmission, to diagnosing infection, to monitoring treatment, to providing essential educational training for healthcare workers.
Injection safety
Leading the supply of safe, effective, auto-disable single-use medication delivery devices
Addressing unmet societal needs with profitable business models
As a company, BD embraces the strategy of shared value.
BD Global Public Health utilizes various methods to achieve positive societal outcomes including public-private partnerships, market development and public policy. BD also works with external funders and scientific collaborators to incubate global health technologies that address unmet needs in emerging nations.
BD has made the following notable advancements:
- The BD Uniject™ auto-disable pre-fillable injection system for family planning
- Partnership for Sayana® Press, an all-in-one injectable contraceptive system that utilizes the BD Uniject auto-disable pre-fillable injection system
- Partnership with CHAI to expand access to CD4 testing
- BD and USAID collaboration to support Indonesia's National Tuberculosis Program (NTP)
Read more about the Shared Value Initiative
At BD, we view sustainability as a portfolio of complementary initiatives and actions that help us achieve our purpose of advancing the world of health. We see the modern social and environmental challenges our world faces as opportunities to make a difference while strengthening our company.
Strategy
Our 2030+ sustainability strategy, which focuses on five impact areas, addresses a range of challenges in our industry while helping to make a difference on relevant issues that affect society and the planet. Our strategy will ensure we remain focused on shared value creation—meaning how we address unmet societal needs through business models and initiatives that also contribute to the commercial success of BD.
UN Sustainable Development Goals
At BD, we actively evaluate how we can mobilize and contribute to the achievement of the UN Sustainable Development Goals (SDGs), through our product and service offerings, as well as collaborative efforts across various sectors-most prominently around SDG3, for good health and well-being. The case study below demonstrates our efforts to advance the SDGs.
BD SUSTAINABILITY REEL
Minimize our contribution to global emissions and utilize our capabilities to address unmet health needs for climate-vulnerable populations.
Reduce the environmental impact of our portfolio and address the sustainability needs of our customers.
Maintain a healthy and thriving workforce that cultivates our culture of inclusion, safety, well-being and contributes to community health.
Invite trust across stakeholder groups through transparent performance reporting on environmental, social and governance (ESG) issues relevant to our business.
Implementing strategy while embracing differences
Our focus is on furthering Inclusion & Diversity (I&D) at BD to drive innovation, to better understand patient and customer needs, and to make BD the best possible place for all people to work. Creating a culture of individual belonging, building and engaging diverse teams and leveraging the unique ideas, backgrounds and experiences of our associates will deliver better outcomes for our global marketplace. At BD, furthering Inclusion and Diversity is not just the right thing to do—it is both a cultural priority and a strategic imperative. This year, we further demonstrated our commitment by creating and staffing a vice president role within our Inclusion and Diversity organization.
The I&D team works with our business, functional and regional leaders, Council, ARGs and Human Resources. Together, they plan, develop and direct strategies to more effectively recruit, develop and retain the Company’s diverse workforce.
The strategic pillars of our Inclusion and Diversity framework continue to include:
- Intensify commitment—launching a Global Inclusion Council comprised of highly influential, next-generation leaders to facilitate action and drive change for their business, region or function
- Build pipeline—launching a pilot development program to accelerate the readiness of diverse internal pipeline talent
- Reshape workplace—completing a workplace fairness assessment of all talent processes and policies to refresh our offerings, starting with a launch of a global Flexible Workplace Policy
- Create mindset—expanding our unconscious bias education to conscious inclusion education
- Set goals and measure outcomes—analyzing results from our annual Voice of Associate (VoA) survey. This will inform the strategic actions we take to continuously improve our culture and better address the needs of all associates
For more details regarding our Inclusion and Diversity strategy and framework, please download and review our most recent report.
BD's Global Inclusion Council launched in 2018 and comprises of senior business leaders representing all of our businesses, regions and functions, and is chaired by Chairman, CEO and President, Tom Polen. The Global Inclusion Council presents an exciting opportunity to advance Inclusion and Diversity at BD and continue to build a high performing culture that allows all associates to be themselves while contributing to – and sharing in – our success as an organization.
ARGs are company-recognized groups of associates with a specific purpose and charter that aligns with the overall company and Inclusion and Diversity strategy. These groups celebrate the differences that make us unique while contributing to and advancing the business.
At BD, ARGs help us advance our cultural priorities of becoming agile and results driven, customer centric and innovative, and inclusive and diverse. ARGs also create professional development opportunities for associates through peer mentoring, coaching, leadership and networking opportunities.
The following ARGs are active within BD today:
- AABD (African-Americans at BD)
- Asian ARG
- HOLA (Hispanic Organization for Leadership and Advancement)
- OPEN (Out and Proud Employee Network/ LGBTA)
- Limitless (Disability-related ARG)
- NEXT (Network for Employee-led Cross-Company Transformation)
- NASSC (North America Shared Service Center)
- VETS (Veteran Employee and Troop Support)
- WIN (Women's Initiative Network)
- Women in STEM
Our most recently filed U.S. Federal Employment Information Report (EEO-1) is available for download. The data in the consolidated EEO-1 report is based on BD’s population in the U.S. in December 2021 and reflects BD’s U.S. workforce as of that time. The EEO-1 report requires that we categorize employees into ten broad EEO-1 Component 1 Data Collection Job Categories. These categories do not necessarily match the job levels in which BD organizes its workforce and evaluates its diversity and inclusion data. Thus, meaningful comparisons between EEO-1 Report data and other descriptions of BD’s diversity statistics and disclosures may not be possible.
BD does not accept unsolicited resumes from agencies.
At BD, we're passionate about advancing the world of health — and that passion extends through our approach to social investing. Our company values guide us to "do what's right," "take personal responsibility," and to "respect, collaborate with, challenge and care about each other." And those commitments apply not just to the way we do business — but also to the ways we give back to the local and global community.
We leverage our expertise to collaborate with leading nonprofit organizations to address unmet healthcare needs. We focus on improving healthcare access and strengthening the capacity of health systems to care for all patients, especially the most vulnerable.
BD partners with leading nonprofit organizations to address unmet healthcare needs. Learn more about our approach to social investing.
BD encourages its employees to get involved and give back to their local communities. Learn how BD encourages employee engagement and volunteerism.
Learn more about BD's approach to disaster response and product donation.